Literature DB >> 15178375

Effects of intravenous infusion of highly purified vitamin B2 on lipopolysaccharide-induced shock and bacterial infection in mice.

Toshio Toyosawa1, Mamoru Suzuki, Kohtarou Kodama, Seiichi Araki.   

Abstract

We investigated the effect of an i.v. infusion of highly purified vitamin B(2) (riboflavin 5'-sodium phosphate: purity >97%) on lipopolysaccharide-induced shock and bacterial infection in mice. Six hours after lipopolysaccharide injection or 1 h after bacterial infection, vitamin B(2) or human activated protein C (APC) was administered by 6-h i.v. infusion. Vitamin B(2) at 10 mg/kg/6 h and up to 80 mg/kg/6 h significantly improved lipopolysaccharide-induced endotoxin shock. APC was also effective at low doses, but was deleterious at higher doses. Moreover, vitamin B(2) at 80 mg/kg/6 h significantly reduced the lethality of Escherichia coli and Staphylococcus aureus infection, whereas APC at up to 600 units/kg/6 h was ineffective. The i.v. infusion of vitamin B(2) reduced the elevations of proinflammatory cytokines and nitric oxide induced by lipopolysaccharide. These results suggest that i.v. infusion of vitamin B(2) represents a promising strategy for the treatment of sepsis and septic shock.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178375     DOI: 10.1016/j.ejphar.2004.04.004

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

Review 1.  Riboflavin in Neurological Diseases: A Narrative Review.

Authors:  Domenico Plantone; Matteo Pardini; Giuseppe Rinaldi
Journal:  Clin Drug Investig       Date:  2021-04-22       Impact factor: 2.859

2.  δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens.

Authors:  Asaf A Qureshi; Julia C Reis; Nilofer Qureshi; Christopher J Papasian; David C Morrison; Daniel M Schaefer
Journal:  Lipids Health Dis       Date:  2011-02-28       Impact factor: 3.876

3.  Anti-inflammatory activity of edible oyster mushroom is mediated through the inhibition of NF-κB and AP-1 signaling.

Authors:  Andrej Jedinak; Shailesh Dudhgaonkar; Qing-Li Wu; James Simon; Daniel Sliva
Journal:  Nutr J       Date:  2011-05-16       Impact factor: 3.271

Review 4.  Update on riboflavin and multiple sclerosis: a systematic review.

Authors:  Mahshid Naghashpour; Sima Jafarirad; Reza Amani; Alireza Sarkaki; Ahmad Saedisomeolia
Journal:  Iran J Basic Med Sci       Date:  2017-09       Impact factor: 2.699

5.  Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.

Authors:  Marjolein A Y Klaassen; Floris Imhann; Valerie Collij; Jingyuan Fu; Cisca Wijmenga; Alexandra Zhernakova; Gerard Dijkstra; Eleonora A M Festen; Ranko Gacesa; Arnau Vich Vila; Rinse K Weersma
Journal:  J Crohns Colitis       Date:  2019-10-28       Impact factor: 9.071

Review 6.  Riboflavin: The Health Benefits of a Forgotten Natural Vitamin.

Authors:  Nittiya Suwannasom; Ijad Kao; Axel Pruß; Radostina Georgieva; Hans Bäumler
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

7.  HMGB1 Inhibition During Zymosan-Induced Inflammation: The Potential Therapeutic Action of Riboflavin.

Authors:  Agnieszka Irena Mazur-Bialy; Ewa Pocheć
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-10-07       Impact factor: 4.291

8.  Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation.

Authors:  Somrita Dey; Biswadev Bishayi
Journal:  J Inflamm (Lond)       Date:  2016-11-28       Impact factor: 4.981

Review 9.  Riboflavin Deficiency-Implications for General Human Health and Inborn Errors of Metabolism.

Authors:  Signe Mosegaard; Graziana Dipace; Peter Bross; Jasper Carlsen; Niels Gregersen; Rikke Katrine Jentoft Olsen
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

10.  Riboflavin, vitamin B2, attenuates NLRP3, NLRC4, AIM2, and non-canonical inflammasomes by the inhibition of caspase-1 activity.

Authors:  Huijeong Ahn; Geun-Shik Lee
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.